Point72 (DIFC)’s Globus Medical GMED Stock Holding History

Point72 (DIFC)’s Portfolio GMED Stock Details GMED Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q1	–	Sell	-107,088	Closed	-$8.86M	–	1819
2024 Q4	$8.86M	Buy	+107,088	New	+$8.45M	0.33%	67

Other funds holding GMED

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

BAM

Burgundy Asset Management Toronto, Ontario, Canada $10.6B AUM 13.39% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

William Blair Investment Management Chicago, Illinois $30.3B AUM 33.75% 1-Year Est. Return

Sculptor Capital New York $9.61B AUM 27.49% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Point72 (DIFC)'s GMED Position: Q1 2025 in Review

Point72 (DIFC) sold out of Globus Medical (GMED) in Q1 2025, closing a stake of 107,088 shares — an estimated $8.86M sold.

Point72 (DIFC) first reported a position in GMED in Q4 2024 and held it in 1 quarter. The position peaked at $8.86M in Q4 2024. 514 funds tracked by Wall St. Rank hold GMED as of Q1 2025.

Point72 (DIFC) reported no remaining Globus Medical position as of Q1 2025 after selling out during the quarter.
Point72 (DIFC) sold 107,088 Globus Medical shares in Q1 2025, an estimated $8.86M.
Point72 (DIFC) first reported a position in Globus Medical in Q4 2024 and held it in 1 quarter.
Point72 (DIFC)'s Globus Medical position peaked at $8.86M in Q4 2024.
514 funds tracked by Wall St. Rank held Globus Medical as of Q1 2025.

Based on Point72 (DIFC)'s 13F filing for Q1 2025, filed 15 May 2025.